Purpose of this Study
We are doing this study to learn more about the side effects of the study drug and to determine if it will help shrink the cancer by at least 30%.
Who Can Participate?
Eligibility
Adults who are diagnosed with brain metastases.
Age Range
18-110
Sex/Genders
Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No
What is Involved?
Description
If you choose to join this study, you will:
- Have blood draws
- Have EKG's (a way to measure your heart activity)
- Take 1 of the 3 study drugs that is assigned to your specific cancer
- Keep a pill diary (to help track when you take your pills)
Locations
Duke University Hospital
Visit Timing
Weekdays
Compensation
No
Spanish Materials Available
Yes
Study Details
Full Title
Alliance A071701: Genomically-Guided Treatment Trial in Brain Metastases
Principal Investigator
Carey
Anders
Protocol Number
PRO00104080
NCT ID
NCT03994796
Phase
II
Enrollment Status
Open to Enrollment